Regenxbio (RGNX) Common Equity (2014 - 2026)
Regenxbio (RGNX) posted Common Equity of $71.77 million for Q2 2026, down 66.4% from $213.68 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Common Equity came in at $102.73 million, down 60.4% from FY2024.
- Annual Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -22.9% (FY2020 to FY2025).
- In prior years, Regenxbio's Common Equity was $259.65 million in FY2024 (-16.7%), $311.74 million in FY2023 (-39.6%), $516.2 million in FY2022 (-32.5%) and $764.3 million in FY2021 (+102.3%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q4 2014.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2021, with growth of 102.3%; the weakest was Q2 2026, with a decline of 66.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Regenxbio | 404.61 Mn | -528.48 Mn | - | 71.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.77 Mn |
| Dec 31, 2025 | 102.73 Mn |
| Sep 30, 2025 | 161.45 Mn |
| Jun 30, 2025 | 213.68 Mn |
| Mar 31, 2025 | 274.20 Mn |
| Dec 31, 2024 | 259.65 Mn |
| Sep 30, 2024 | 301.42 Mn |
| Jun 30, 2024 | 348.27 Mn |
| Mar 31, 2024 | 390.67 Mn |
| Dec 31, 2023 | 311.74 Mn |
| Sep 30, 2023 | 363.10 Mn |
| Jun 30, 2023 | 405.86 Mn |
| Mar 31, 2023 | 465.14 Mn |
| Dec 31, 2022 | 516.20 Mn |
| Sep 30, 2022 | 563.82 Mn |
| Jun 30, 2022 | 630.52 Mn |
| Mar 31, 2022 | 689.67 Mn |
| Dec 31, 2021 | 764.30 Mn |
| Sep 30, 2021 | 461.41 Mn |
| Jun 30, 2021 | 507.25 Mn |
API Access
Regenxbio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();